checkAd
    Startseite > Aktien > Capricor Therapeutics > Nachrichten
    Capricor Therapeutics Aktie
    5,3300
     
    USD
    -1,48 %
    -0,0800 USD
    Letzter Kurs 02:00:00 Nasdaq
    5,3300
     
    USD
    200 STK
    Geldkurs 29.04.24
    5,3600
     
    USD
    1.300 STK
    Briefkurs 29.04.24
    ISIN: US14070B3096 · WKN: A2PLU4 · SYM: CAPR · USA

    Neueste Nachrichten

    Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
    24.04.24 · globenewswire · Capricor Therapeutics
    Capricor Therapeutics to Present at Upcoming Investor Conferences
    21.03.24 · globenewswire · Capricor Therapeutics
    Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
    06.03.24 · globenewswire · Capricor Therapeutics
    Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    29.02.24 · globenewswire · Capricor Therapeutics
    Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy
    27.02.24 · globenewswire · Capricor Therapeutics
    Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29
    22.02.24 · globenewswire · Capricor Therapeutics
    Capricor Therapeutics Announces Manufacturing Scale-Up of CAP-1002 Production at New San Diego Facility as it Continues Plans Toward Commercialization
    20.02.24 · globenewswire · Capricor Therapeutics
    Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2
    24.01.24 · globenewswire · Capricor Therapeutics
    Capricor Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
    14.11.23 · globenewswire · Capricor Therapeutics
    Capricor Therapeutics to Present Third Quarter 2023 Financial Results and Recent Corporate Update on November 14
    07.11.23 · globenewswire · Capricor Therapeutics
    Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Review Latest Developments of CAP-1002 Program
    19.10.23 · globenewswire · Capricor Therapeutics
    Capricor Therapeutics Announces Late-Breaking Presentations at 28th Annual Congress of the World Muscle Society
    10.10.23 · globenewswire · Capricor Therapeutics